{
  "id": "56c1d856ef6e394741000032",
  "type": "factoid",
  "question": "Which pathway is activated by ficolin-3?",
  "ideal_answer": "Ficolin-3 activates lectin complement pathway.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/18006063",
    "http://www.ncbi.nlm.nih.gov/pubmed/25069872",
    "http://www.ncbi.nlm.nih.gov/pubmed/19939495",
    "http://www.ncbi.nlm.nih.gov/pubmed/19535802",
    "http://www.ncbi.nlm.nih.gov/pubmed/23142462",
    "http://www.ncbi.nlm.nih.gov/pubmed/24336142",
    "http://www.ncbi.nlm.nih.gov/pubmed/21890891",
    "http://www.ncbi.nlm.nih.gov/pubmed/18261799",
    "http://www.ncbi.nlm.nih.gov/pubmed/25178935"
  ],
  "snippets": [
    {
      "text": "This study aims to investigate whether an association exists between the ficolins that are part of the lectin complement pathway and SLE. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25069872",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ficolin-3 (also called H-ficolin or Hakata antigen) is a complement-activating pattern recognition molecule, possessing a fibrinogen-like domain involved in carbohydrate binding. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25178935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Lectin pathway activity via Ficolin-3 was measured in ELISA on acetylated bovine serum albumin (acBSA) and measured as Ficolin-3 binding and deposition of C4, C3 and the terminal complement complex (TCC).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25069872",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Furthermore, Ficolin-3 mediated complement activation may be valuable in monitoring disease activity in SLE patients due to the high sensitivity for complement consumption in the assay independent of the Ficolin-3 concentration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25069872",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "OBJECTIVES: To assess the involvement of ficolin-3, the main initiator of the lectin complement pathway (LCP), in subarachnoid hemorrhage (SAH) pathology and outcome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336142",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "CONCLUSION: Our data provide evidence that LCP is activated after SAH and that the actual plasma concentrations of ficolin-3 reflect the severity of brain injury as evaluated by clinical and structural parameters. These results support the idea that ficolin-3-mediated functional LCP activity may be targeted to control injury progression in SAH.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336142",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ficolin-3-mediated lectin complement pathway activation in patients with subarachnoid hemorrhage.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336142",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19939495",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Moreover, Ficolin-3 has a high complement activating potential and is the only collagenase proteolytic resistant molecule among the lectin complement pathway initiators.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18006063",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Moreover, Ficolin-3 is the primary acceptor molecule of MASP-3 among the LCP activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19939495",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ficolin-3 (Hakata antigen or H-ficolin) is a soluble pattern recognition molecule in the lectin complement pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18261799",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ficolin-3, encoded by the FCN3 gene and expressed in the lung and liver, is a recognition molecule in the lectin pathway of the complement system.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19535802",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ficolin-1, -2 and -3 are recognition molecules in the lectin complement pathway and form complexes with serine proteases named MASP-1, -2 and -3 and two nonenzymatic proteins. MASP-2 is the main initiator of lectin pathway activation, while ficolin-3 is the most abundant ficolin molecule in the circulation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23142462",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Ficolin-3 (also called H-ficolin or Hakata antigen) is a complement-activating pattern recognition molecule, possessing a fibrinogen-like domain involved in carbohydrate binding. Amongst human ficolins, Ficolin-3 has the highest concentration in serum and is the most potent lectin pathway activator in vitro.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25178935",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Moreover, Ficolin-3 is the primary acceptor molecule of MASP-3 among the LCP activator molecules, but MASP-3 appears to down-regulate Ficolin-3 mediated complement activation through the lectin pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19939495",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Moreover, these LPS/ficolin-3 complexes activated the lectin pathway of complement in a C4b-deposition assay in a calcium- and magnesium-dependent way.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21890891",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [
    "http://www.uniprot.org/uniprot/FCN3_HUMAN"
  ],
  "exact_answer": "lectin complement pathway"
}